NO153102C - Analogifremgangsmaate for fremstilling av terapeutisk aktiv 9 alfa, 11 beta-diklor-16 alfa-methyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-dien-3,20-dion. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktiv 9 alfa, 11 beta-diklor-16 alfa-methyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-dien-3,20-dion.

Info

Publication number
NO153102C
NO153102C NO802256A NO802256A NO153102C NO 153102 C NO153102 C NO 153102C NO 802256 A NO802256 A NO 802256A NO 802256 A NO802256 A NO 802256A NO 153102 C NO153102 C NO 153102C
Authority
NO
Norway
Prior art keywords
alfa
oxycarbonyldicyclohexyl
methyloxypregna
dichlor
dion
Prior art date
Application number
NO802256A
Other languages
English (en)
Norwegian (no)
Other versions
NO153102B (no
NO802256L (no
Inventor
Jean-Georges Teutsch
Roger Deraedt
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO802256L publication Critical patent/NO802256L/no
Publication of NO153102B publication Critical patent/NO153102B/no
Publication of NO153102C publication Critical patent/NO153102C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO802256A 1979-07-26 1980-07-25 Analogifremgangsmaate for fremstilling av terapeutisk aktiv 9 alfa, 11 beta-diklor-16 alfa-methyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-dien-3,20-dion. NO153102C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7919296A FR2462443A1 (fr) 1979-07-26 1979-07-26 Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament

Publications (3)

Publication Number Publication Date
NO802256L NO802256L (no) 1981-01-27
NO153102B NO153102B (no) 1985-10-07
NO153102C true NO153102C (no) 1986-01-15

Family

ID=9228325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802256A NO153102C (no) 1979-07-26 1980-07-25 Analogifremgangsmaate for fremstilling av terapeutisk aktiv 9 alfa, 11 beta-diklor-16 alfa-methyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-dien-3,20-dion.

Country Status (20)

Country Link
US (1) US4353899A (it)
JP (1) JPS5622798A (it)
AT (1) AT371483B (it)
AU (1) AU528292B2 (it)
BE (1) BE884494A (it)
CA (1) CA1141751A (it)
CH (1) CH645389A5 (it)
DE (1) DE3028255C2 (it)
DK (1) DK146690C (it)
FI (1) FI66880C (it)
FR (1) FR2462443A1 (it)
GB (1) GB2054600B (it)
HU (1) HU180364B (it)
IE (1) IE50031B1 (it)
IT (1) IT1145302B (it)
MX (1) MX6649E (it)
NL (1) NL8004282A (it)
NO (1) NO153102C (it)
SE (1) SE447387B (it)
ZA (1) ZA803867B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments
FR2561919B1 (fr) * 1984-04-03 1986-12-19 Roussel Uclaf Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
DE19932511A1 (de) * 1999-07-12 2001-01-18 Helmig Hans Gmbh Schaltvorrichtung für eine Kettengangschaltung zur Betätigung der Kettenradgruppe an der Tretkurbel eines Fahrrades

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122815C (it) * 1963-12-19
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane

Also Published As

Publication number Publication date
AT371483B (de) 1983-06-27
DK146690C (da) 1984-05-21
NL8004282A (nl) 1981-01-28
SE8004428L (sv) 1981-01-27
MX6649E (es) 1985-10-01
CA1141751A (fr) 1983-02-22
FI802092A (fi) 1981-01-27
HU180364B (en) 1983-02-28
GB2054600A (en) 1981-02-18
GB2054600B (en) 1983-02-02
FI66880C (fi) 1984-12-10
CH645389A5 (fr) 1984-09-28
ZA803867B (en) 1981-06-24
IT1145302B (it) 1986-11-05
DK321180A (da) 1981-01-27
ATA391380A (de) 1982-11-15
NO153102B (no) 1985-10-07
FR2462443A1 (fr) 1981-02-13
IE801561L (en) 1981-01-26
US4353899A (en) 1982-10-12
IE50031B1 (en) 1986-02-05
SE447387B (sv) 1986-11-10
JPS5622798A (en) 1981-03-03
DE3028255C2 (de) 1985-12-19
FR2462443B1 (it) 1982-12-31
DE3028255A1 (de) 1981-02-19
NO802256L (no) 1981-01-27
DK146690B (da) 1983-12-05
AU6081180A (en) 1981-01-29
FI66880B (fi) 1984-08-31
AU528292B2 (en) 1983-04-21
JPS6254438B2 (it) 1987-11-14
IT8049248A0 (it) 1980-07-15
BE884494A (fr) 1981-01-26

Similar Documents

Publication Publication Date Title
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO154058C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO155290C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme sulfonylurinstoffderivater.
NO150361C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(1h-tetrazol-5-yl)-4h-(pyrido-(1,2-a)-pyrimidin-4-on-derivater
NO151362C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater.
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO163285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO155665C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
NO155244C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-substituert-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer fra deres tilsvarende nitriler.
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
NO147483C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.